文献速递产科妇科

妇产科药物过敏的诊断与临床管理:专家综述

Diagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review.
PubMed 文献 · Am J Obstet Gynecol · 2024-10-28

本文综述妇产科药物过敏(尤其抗生素过敏)的诊断与管理。美国10%人群报告青霉素过敏,但>90%报告者并非真过敏。过敏评估(详细病史、皮试和/或口服激发)在孕期安全有效,可增加一线抗生素使用。头孢菌素交叉反应率低(确证青霉素过敏者2%–3%),指南支持在未确证非速发型青霉素过敏者中常规使用头孢菌素。必要时可行脱敏治疗。

要点

  • >90%报告青霉素过敏者并非真过敏,过敏评估在孕期安全有效。
  • 确证青霉素过敏者头孢菌素交叉反应率仅2%–3%,未确证者更低。
  • 指南支持未确证非速发型青霉素过敏者常规使用头孢菌素,无需皮试或额外预防。

核心结论

  • 妇产科医生应识别报告药物过敏的患者并尽快转诊至专科进一步评估;按指征进行详细病史和过敏检测(皮试和/或口服激发)安全有效,是抗生素管理的重要部分。

研究设计与样本

  • 专家综述,检索范围原文未报告。

主要发现

  • 美国10%人群报告青霉素过敏,但>90%报告者并非真过敏,可耐受青霉素。
  • 替代抗生素使用与剖宫产、子宫内膜炎、伤口并发症、孕妇住院时间延长、B族链球菌脓毒症、新生儿住院时间延长、新生儿采血、妇科手术部位感染增加相关,并导致抗生素耐药、毒性和医疗费用增加。
  • 确证青霉素过敏者头孢菌素交叉反应率估计为2%–3%,未确证青霉素过敏者 considerably lower。
  • 过敏评估(详细病史和过敏检测)在孕妇和非孕妇中安全有效,适当使用可增加一线抗生素使用。

关键数值与推荐

  • 指南支持未确证非速发型青霉素过敏者常规使用头孢菌素,无需皮试或额外预防。
  • 指南支持即使速发型青霉素过敏者也可常规使用结构不同的头孢菌素( specifically Ancef)。
  • 甲硝唑过敏皮试缺乏敏感性和特异性,低风险患者首选口服激发,高风险患者首选脱敏。
  • 脱敏治疗通过暴露于少量过敏原直至达到治疗剂量,临时诱导药物耐受,已在孕期安全实施,需专家监督,最常在重症监护环境中由多学科团队执行。

临床怎么用

  • 妇产科医生应识别报告药物过敏的患者并尽快转诊至专科进一步评估。
  • 按指征进行详细病史和过敏检测(皮试和/或口服激发)安全有效,是抗生素管理的重要部分。
  • 无合适替代抗生素时(如孕妇梅毒青霉素过敏),可进行脱敏治疗,需专家监督,最常在重症监护环境中由多学科团队执行。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Drug allergies, specifically antibiotic allergies, are frequently encountered in obstetrics and gynecology, with 10% of the US population reporting a penicillin allergy. This poses a particular challenge to the obstetrician-gynecologist, as beta-lactam antibiotics are indicated as first-line therapy for the treatment and prevention of most specialty-specific infections. Alternative antibiotic use in the setting of a reported allergy is not benign and has been associated with increased cesarean delivery, endometritis, wound complication, length of hospital stay in pregnant patients, Group B Streptococcus sepsis, neonatal length of stay, neonatal laboratory draw in neonates born to patients with allergies, and surgical site infection in gynecologic patients. Furthermore, alternative antibiotic use leads to increased antibiotic resistance, toxicity, and healthcare cost. In addition, the administration of antibiotics in a patient with a history of type I immediate hypersensitivity reaction poses a risk of anaphylaxis with repeat exposure. Fortunately, >90% of patients who report a penicillin allergy are not truly allergic and would tolerate penicillins if administered. This can be due to either mislabeling of the index reaction as an allergy (when it was due to a drug intolerance or a viral exanthem) or waning immunoglobulin E-mediated immunity over time. Given this, allergy evaluation is widely recommended, even in pregnancy. Allergy evaluation involves detailed patient history and allergy testing with skin testing and/or oral challenge, as appropriate. These tools have been found to be safe and effective in gravid and nongravid individuals and to result in increased use of first-line antibiotics when used appropriately. Furthermore, even in the setting of a true penicillin allergy, cross-reactivity with cephalosporins is extremely low and estimated at 2% to 3% among patients with a verified penicillin allergy and considerably lower than this among patients with an unverified penicillin allergy. Guidelines support the routine use of cephalosporins without testing or additional precautions in patients with an unverified nonanaphylactic penicillin allergy and the routine use of structurally dissimilar cephalosporins (specifically Ancef) even in patients with an anaphylactic penicillin allergy. In cases in which there is no appropriate alternative antibiotic than that for which the patient is allergic, such as syphilis in a pregnant patient with penicillin allergy, desensitization can be performed. This process involves temporary induction of drug tolerance through exposure to small amounts of the allergen until a therapeutic dose is achieved and has been safely performed in pregnancy. Desensitization requires expert supervision and is most often performed in the intensive care setting with a multidisciplinary team. The other 2 most common antibiotic allergies encountered in the field of obstetrics and gynecology are cephalosporin and metronidazole allergies. Cephalosporin allergies are managed similarly to penicillin allergies with readily available skin testing and oral challenge. Skin testing for metronidazole allergy lacks sensitivity and specificity, and thus, oral challenge or desensitization procedure is the preferred approach for low-risk and high-risk patients, respectively. When it comes to drug allergies, specifically antibiotic allergies, the role of the obstetrician-gynecologist is to identify patients with reported allergies and to refer patients to a specialist for further evaluation as soon as possible. Allergy evaluation using a detailed patient history and allergy testing (skin testing and/or oral challenge) when indicated has been shown to be safe and effective and is an important part of antibiotic stewardship.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Burn MS, Kwah JH, Son M, et al. Diagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review. Am J Obstet Gynecol. 2024. PMID: 39490659. doi:10.1016/j.ajog.2024.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。